Publication: Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
Métricas
Gestores bibliográficos
Compartir
Authors
Giuliano, Anna
Palefsky, Joel
Goldstone, Stephen
Bornsteind, Jacob
De Coster, Ilse
Guevara, Ana
Mogensen, Ole
Van Damme, Pierre
Vandermeulen, Corinne
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
Acceso Abierto
item.page.other
item.page.references
Abstract
Post hoc analyses of 9-valent human papillomavirus (9vHPV) vaccine immunogenicity were conducted in five Phase 3 studies that enrolled males. Month 7 antibody geometric mean titers (GMTs) after three ...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Giuliano AR, Palefsky JM, Goldstone SE, Bornstein J, De Coster I, Guevara AM, Mogensen O, Schilling A, Van Damme P, Vandermeulen C, Ellison MC; Thomas Group; Kaplan S, Lin J, Bonawitz R, Luxembourg A. Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies. Hum Vaccin Immunother. 2025 Dec;21(1):2425146. doi: 10.1080/21645515.2024.2425146
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
2 1,5 1 0,5 0
Marzo 2026Abril 2026Mayo 2026Junio 2026Julio 2026Agosto 2026Septiembre 2026
Loading...
Loading...
Loading...